Skip to main content
EJNMMI Radiopharmacy and Chemistry
Fig. 7 | EJNMMI Radiopharmacy and Chemistry

Fig. 7

From: Development of [225Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibration

Fig. 7

A Alpha energy spectrum determined using ORTEC® Alpha Duo Integrated Alpha Spectrometer. B Measured activity of Ac-225 and decay products determined via alpha and gamma spectrometry. C Linear relationship between counts per minute determined using WIZARD2 automatic gamma counter and activity per unit derived from HPGD. D Measured activity of alpha, beta, and gamma emissions from Ac-225 decay

Back to article page